Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

A Systematic Search Into The Role Of IGHV Gene Replacement In Shaping The Immunoglobulin Repertoire Of Chronic Lymphocytic Leukemia

Sophia Yancopoulos, PhD, Xiao-Jie Yan, MD PhD, Andreas Agathangelidis, Wentian Li, Ph.D., Chrysoula Belessi, Paolo Ghia, MD, PhD, Richard Rosenquist, MD, PhD, Frederic Davi, MD, PhD, David Graham Oscier, MD, Sarka Pospisilova, Panagiotis Panagiotidis, MD, Lin Huang, PhD, Zhixin Zhang, PhD, Steven L. Allen, MD, Jaqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Kanti R. Rai, MD, Kostas Stamatopoulos, MD, Nicholas Chiorazzi, MD

Blood (2013) 122 (21): 4129.

https://doi.org/10.1182/blood.V122.21.4129.4129

Published: 2013

Journal Articles

SNP-Arrays Provide New Insights Into the Pathogenesis of Richter Syndrome (RS)

Blood (2011) 118 (21): 263.

https://doi.org/10.1182/blood.V118.21.263.263

Published: 2011

Journal Articles

Polyclonal Serum FLC Levels: a Simple Risk Stratification Model for Identifying Aggressive Stage A CLL.

Guy Pratt, Alison Levoguer, Jeffrey Faint, Chris Fegan, Chris Pepper, David Graham Oscier, MD, Anne Gardiner, Stephen Harding, PhD

Blood (2010) 116 (21): 4608.

https://doi.org/10.1182/blood.V116.21.4608.4608

Published: 2010

Journal Articles

13q Deletion Size Predicts Disease Progression and Response to Treatment in Patients with Chronic Lymphocytic Leukaemia.

Jonathan C Strefford, PhD, Helen Parker, PhD, Anton Parker, BSc, Hazel Robinson, PhD, Tracy Chaplin, MSc, Xiao-He Chen, PhD, David Bunyan, PhD, Anne Gardiner, BSc, Bryan D Young, PhD, David Graham Oscier, MD

Blood (2009) 114 (22): 671.

https://doi.org/10.1182/blood.V114.22.671.671

Published: 2009

Journal Articles

Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion

David Gonzalez, PhD, Pilar Martinez, MD, PhD, Rachel Wade, Sarah Lorna Hockley, PhD, Vasantha Brito-Babapulle, PhD, David Graham Oscier, MD, Estella Matutes, MD, PhD, Claire E Dearden, Sue Richards, Daniel Catovsky, MD, Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 784.

https://doi.org/10.1182/blood.V112.11.784.784

Published: 2008

Journal Articles

Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Catabolic Chemical Modifications

Rosa Catera, Gregg J. Silverman, Katerina Hatzi, Till Seiler, Sebastien Didier, Lu Zhang, MA, Maxime Hervé, Eric Meffre, David Graham Oscier, MD, Helen Vlassara, Yifang Chen, Steven L. Allen, Kanti R. Rai, MD, Charles C. Chu, PhD, Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 3150.

https://doi.org/10.1182/blood.V112.11.3150.3150

Published: 2008

Journal Articles

Epigenetic Regulation of ZAP70 in Chronic Lymphocytic Leukemia.

Anton Parker, Shilu Amin, Tricia Zwiefelhofer, Ben Gregory, Helen White, PhD, Oliver Giles Best, PhD, Nick Cross, PhD, Jelena Mann, PhD, Mathias Ehrich, MD, David Graham Oscier, MD

Blood (2008) 112 (11): 2246.

https://doi.org/10.1182/blood.V112.11.2246.2246

Published: 2008

Journal Articles

A Novel Functional Assay Using Etoposide Plus Nutlin 3, FISH and Mutational Analysis Detects Heterogeneity of ATM/p53 Pathway Alterations in CLL.

Giles Best, PhD, Anne Gardiner, BSc, Rachel Ibbotson, PhD, Aneela Majid, PhD, Renata Walewska, MD, Belinda Austen, MD, Tanja Stankovic, PhD, Martin Dyer, MD, David Graham Oscier, MD

Blood (2006) 108 (11): 2795.

https://doi.org/10.1182/blood.V108.11.2795.2795

Published: 2006

Journal Articles

The Utility of V617F JAK2 Analysis for Patients with Erythrocytosis or Thrombocytosis in the General Hospital.

David Graham Oscier, MD, Amy Jones, BSc, Louise Wallis, SRN, Joe Chacko, MD, Nicholas C.P. Cross, PhD

Blood (2006) 108 (11): 3630.

https://doi.org/10.1182/blood.V108.11.3630.3630

Published: 2006

Journal Articles

Defining the 10 Year Risk of Disease Progression in Stage A0 CLL.

Anne Gardiner, BSc, Zadie Davis, MSc, Parker Anton, BSc, Giles Best, PhD, Rachel Ibbotson, PhD, Sarah Mould, BSc, Sharron Glide, BSc, Peter Thomas, PhD, Jenny Orchard, MD, David Graham Oscier, MD

Blood (2006) 108 (11): 2772.

https://doi.org/10.1182/blood.V108.11.2772.2772

Published: 2006

Journal Articles

Polyreactive Monoclonal Antibodies Synthesized by Some B-CLL Cells Recognize Specific Antigens on Viable and Apoptotic T Cells.

Rosa Catera, PhD, Katerina Hatzi, Charles C. Chu, PhD, Maxime Herve’, Eric Meffre, PhD, Manlio Ferrarini, MD, David Graham Oscier, MD, Zadie Davis, Steven L. Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2006) 108 (11): 2813.

https://doi.org/10.1182/blood.V108.11.2813.2813

Published: 2006

Journal Articles

Restricted MHC Phenotypes in Lymphoproliferative Disorders with Non-Random Immunoglobulin Variable Gene Usage: Evidence for Antigen-Specific Interactions between Tumor and Microenvironment.

Ann M. Little, PhD, Zadie Davis, MSC, Finulla Fowles, BSc, Julie Richards, PhD, David Graham Oscier, MD, Stephen Devereux, MD, PhD

Blood (2006) 108 (11): 2818.

https://doi.org/10.1182/blood.V108.11.2818.2818

Published: 2006

Journal Articles

Prognostic Factors in the UK LRF CLL4 Trial.

David Graham Oscier, MD, Rachel Wade, MSc, Jenny Orchard, MD, Zadie Davis, MSc, Giles Best, PhD, Alison Morilla, BSc, Vasantha Brito-Bapapulle, PhD, Estella Matutes, MD, Sue Richards, DPhil, Daniel Catovsky, MD

Blood (2006) 108 (11): 299.

https://doi.org/10.1182/blood.V108.11.299.299

Published: 2006

Journal Articles

Drug Sensitivity by TRAC (DiSC) Assay as a Prognostic Factor for Patient Response in Untreated CLL: Results from the UK LRF CLL4 Trial.

Andrew G. Bosanquet, PhD, Steve L. Raper, BSc, Justin Durant, Sheila M. Scadding, David Graham Oscier, MD, Sue M. Richards, PhD, Daniel Catovsky, MD PhD, on Behalf of the NCRI CLL Working Group

Blood (2006) 108 (11): 303.

https://doi.org/10.1182/blood.V108.11.303.303

Published: 2006

Journal Articles

VH Gene Analysis in Splenic Marginal Zone Lymphoma Identifies Patients with Structurally Similar B Cell Receptors but Does Not Provide Prognostic Information.

David Graham Oscier, MD, Zadie Davis, MSc, Patricia Algara, MD, Alexandra Traverse-Glehen, MD, Kostos Stamatopoulos, MD, Jan Delabie, MD, Anne Gardiner, BSc, Chrysoula Belessi, MD, Nikolaos Loutaris, MD, Estella Matutes, MD, Gilles Salles, MD, Manuela Mollejo, MD, Miguel Piris, MD

Blood (2006) 108 (11): 2421.

https://doi.org/10.1182/blood.V108.11.2421.2421

Published: 2006

Journal Articles

Splenic Marginal Zone Lymphoma Shows a Distinct Pattern of DNA Copy Number Aberrations That Correlates with Tumor Characteristics and Predicts Disease Outcome.

Jose A. Martinez-Climent, MD, PhD, Cristina Robledo, MSc, Manuela Mollejo, MD, Anton Parker, MD, Juan L. Garcia, PhD, Carlos Panizo, MD, Lorena Fontan, PhD, Vicente Fresquet, PhD, Ellen D. Remstein, MD, Sara Mould, MD, Ahmet Dogan, MD, Mark Law, MD, Isabel Marugan, MD, Maria J. Terol, MD, Esperanza Vizcarra, MD, David Graham Oscier, MD, Miguel A. Piris, MD, Jose M. Hernandez-Rivas, MD

Blood (2006) 108 (11): 2422.

https://doi.org/10.1182/blood.V108.11.2422.2422

Published: 2006

Journal Articles

Prognostic Factors in the UK LRF CLL4 Trial.

David Graham Oscier, MD, Sue Richards, DPhil, Jenny Orchard, MD, Zadie Davis, MSc, Giles Best, PhD, Alison Morilla, BSc, Vasantha Brito-Bapapulle, PhD, Estella Matutes, MD, Andrew Pettitt, MD, Daniel Catovsky, MD

Blood (2005) 106 (11): 2099.

https://doi.org/10.1182/blood.V106.11.2099.2099

Published: 2005

Journal Articles

Telomere Length by Tel-PCR in B Cell Malignancies.

Anton E. Parker, BSc, Kimberley Snell, Zadie Davis, MSc, David Graham Oscier, MD

Blood (2005) 106 (11): 2955.

https://doi.org/10.1182/blood.V106.11.2955.2955

Published: 2005

Journal Articles

The Natural History of Mutated, Stage AO Chronic Lymphocytic Leukemia.

David Graham Oscier, MD, Anne C. Gardiner, BSc, Sarah J. Mould, BSc, Sharron Glide, BSc, Zadie A. Davis, BSc, Martin Corcoran, PhD, Adrian Wiestner, MD, Louis M. Staudt, MD, Peter Thomas, PhD, Jenny A. Orchard, MD

Blood (2004) 104 (11): 954.

https://doi.org/10.1182/blood.V104.11.954.954

Published: 2004

Journal Articles

Zap70 Methylation Correlates with Zap70 Expression in Chronic Lymphocytic Leukemia.

David Graham Oscier, MD, Anton Parker, BSc, Zadie Davis, MSc, Wirtz Michaela, MSc, Schmitz Oliver, PhD, Jenny Orchard, MD, Martin Corcoran, PhD

Blood (2004) 104 (11): 962.

https://doi.org/10.1182/blood.V104.11.962.962

Published: 2004

NARROW

A Systematic Search Into The Role Of IGHV Gene Replacement In Shaping The Immunoglobulin Repertoire Of Chronic Lymphocytic Leukemia

SNP-Arrays Provide New Insights Into the Pathogenesis of Richter Syndrome (RS)

Polyclonal Serum FLC Levels: a Simple Risk Stratification Model for Identifying Aggressive Stage A CLL.

13q Deletion Size Predicts Disease Progression and Response to Treatment in Patients with Chronic Lymphocytic Leukaemia.

Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion

Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Catabolic Chemical Modifications

Epigenetic Regulation of ZAP70 in Chronic Lymphocytic Leukemia.

A Novel Functional Assay Using Etoposide Plus Nutlin 3, FISH and Mutational Analysis Detects Heterogeneity of ATM/p53 Pathway Alterations in CLL.

The Utility of V617F JAK2 Analysis for Patients with Erythrocytosis or Thrombocytosis in the General Hospital.

Defining the 10 Year Risk of Disease Progression in Stage A0 CLL.

Polyreactive Monoclonal Antibodies Synthesized by Some B-CLL Cells Recognize Specific Antigens on Viable and Apoptotic T Cells.

Restricted MHC Phenotypes in Lymphoproliferative Disorders with Non-Random Immunoglobulin Variable Gene Usage: Evidence for Antigen-Specific Interactions between Tumor and Microenvironment.

Prognostic Factors in the UK LRF CLL4 Trial.

Drug Sensitivity by TRAC (DiSC) Assay as a Prognostic Factor for Patient Response in Untreated CLL: Results from the UK LRF CLL4 Trial.

VH Gene Analysis in Splenic Marginal Zone Lymphoma Identifies Patients with Structurally Similar B Cell Receptors but Does Not Provide Prognostic Information.

Splenic Marginal Zone Lymphoma Shows a Distinct Pattern of DNA Copy Number Aberrations That Correlates with Tumor Characteristics and Predicts Disease Outcome.

Prognostic Factors in the UK LRF CLL4 Trial.

Telomere Length by Tel-PCR in B Cell Malignancies.

The Natural History of Mutated, Stage AO Chronic Lymphocytic Leukemia.

Zap70 Methylation Correlates with Zap70 Expression in Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only